Global Health Bodies Could Team Up to Tackle Funding Crisis
LONDON (Reuters) -Two global health groups that fund billions of dollars worth of critical medical aid - from childhood vaccines to malaria treatments - are in talks about merging some functions to help combat a financing crunch, their chief executives told Reuters.
The groups – the Global Fund to Fight AIDS, Tuberculosis and Malaria and the vaccine group Gavi – said they had been discussing working more efficiently together for several years, but a massive pull-back on government-funded aid budgets, led by the Trump administration, has given the talks more urgency.
'I think the crisis – and it is a crisis, what we're facing in global health right now – is an impetus to think hard about the shape and structure of the global health ecosystem,' Peter Sands, chief executive of the Global Fund, told Reuters.
Gavi and the Global Fund set up a working group in autumn last year to work more closely together and explore merging some functions, joined by the World Bank's Global Financing Facility for women and girls. The group's work, which is ongoing, has not been previously reported.
'The idea is not to bring these massive structures together, the idea is to work better at the country level… to make life for countries easier,' said Sania Nishtar, Gavi chief executive.
Sands and Nishtar spoke to Reuters during the World Health Organization's annual meeting in Geneva, at which budget cuts and efficiencies were high on the agenda.
Nishtar gave an example of Gavi in Nigeria helping local health officials give children measles and rubella vaccines, while Global Fund supported them giving bed nets to their parents to help prevent malaria. Previously, the two groups might have had separate desks, supply chains, data, staff, logistics, and guidelines, and even warehouses. That should be done better, she said.
Working together on rolling out the malaria vaccine, led by Gavi, alongside other malaria tools like preventive drugs, which the Global Fund manages, had also prompted greater cooperation.
The Global Fund is trying to raise $18 billion for its work from 2027-2029, and Gavi is trying to raise $9 billion for 2026-2030.
Donors told Reuters that they are pushing for efficiencies as they consider how much to pledge to the groups, which have saved millions of lives since beginning work in the early 2000s.
A Gavi spokesperson said it had started a voluntary departure scheme among its 650 staff and consultants and was working to streamline operations. The Global Fund has around 1,200 staff and declined to comment on potential cuts.
Advocates including Bill Gates, a major global health funder through his foundation, said he had been talking to governments about the essential role the two organisations play.
'Being an advocate and making sure the money is well-spent, that is part of my role,' he told Reuters earlier this month.
(Reporting by Jennifer Rigby, editing by Michele Gershberg and Elaine Hardcastle)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
2 hours ago
- New York Times
Nottingham Forest hope Nicolas Dominguez will recover from knee injury before start of new season
Nottingham Forest hope that Nico Dominguez will recover for the start of the new Premier League season after the midfielder suffered a knee injury. Dominguez has had to withdraw from international duty with Argentina because of the problem, which has seen him require treatment to repair a meniscus issue. Advertisement The 26-year-old established himself as a regular under Nuno Espirito Santo in the final stages of the campaign, as Forest secured European football for the first time in three decades. His form was enough to earn him a call-up for the World Cup qualifiers in Chile on June 6 and at home to Colombia on June 11. Dominguez last played for his country in a 0-0 draw with Brazil in November 2021, but will have to wait a little while longer for his next cap. Dominguez, who signed from Bologna in September 2023, made 23 starts and 11 substitute appearances in the top flight for Forest last season, as Forest pushed for a top-five finish – before ultimately finishing seventh, to secure a place in the Conference League next season. The player, who began his career at Velez Sarsfield in his home country, will be assessed in the coming weeks and throughout pre-season. But there is a hope that he could yet return for the start of the new campaign in August, if his recovery timeline goes positively.
Washington Post
2 hours ago
- Washington Post
Political idiocy is going to make us, well, idiots
In today's edition: You walk into the pharmacy in Idaho and pick up the pamphlet that says 'Ivermectin and You.' You open it. Instead of information, loose pills simply tumble out. You ask the pharmacist about vaccines, and she pretends she hasn't heard you. This, my friends, is medical freedom. Leana Wen's latest column is a case study of the right's antipathy toward the medical establishment, chronicling how ivermectin — long used for deworming livestock — gained conservative cachet during the covid-19 pandemic and is now being made available over the counter in a bunch of red states; meanwhile, vaccine access is being 'sacrificed on the altar of contrarianism.' Yes, Leana says, 'proponents hail these moves as a win for the 'medical freedom' movement,' but they are in fact the manifestation of a diseased relationship with public health and science writ large. To wit: Vice President JD Vance doesn't seem to have a very good grasp on how America's space program happened, Mark Lasswell writes: Vance claims 'American talent' powered the program, with a teeny bit of help from 'some German and Jewish scientists' who came to this country from Europe. 'Some'? Mark entreats us to remember rocketry mastermind Wernher von Braun. Oh, of the Philadelphia von Brauns? Not quite. True, a lot of those contributors became Americans in the 1950s — but Vance doesn't appear too keen on the whole naturalization thing, either. All of this pairs very poorly with, as Mark writes, the White House 'working energetically to dissolve arrangements between several research universities and the government.' Max Boot characterizes it even more starkly: 'the suicide of a superpower.' That's because a lot of progress really has been the result of American ingenuity, which happens to occur largely at universities funded by the government. Examples include: the internet, GPS, smartphones, artificial intelligence, MRIs, LASIK, Ozempic, and drugs that actually prevent and treat covid. But, years hence, as our adversaries explore the cosmos, the human genome and the limits of generative AI, at least we will be worm-free. Chaser: Professor Carole LaBonne writes that it's true that colleges have benefited plenty from federal funding, but if we're looking at which way the reliance relationship really goes, it's the government that depends on universities. From Perry Bacon's essay on the way 'flyover country' conquered this basketball season, with the Indiana Pacers and Oklahoma City Thunder heading to the NBA Finals. 'Is the NBA self-sabotaging? Does the league just have terrible luck?' Perry asks. 'No and no. Teams in fairly small markets will host the championships for a league that craves a massive and even international audience. And that's just fine.' The league, Perry writes, will have plenty of money no matter how many viewers tune in to this year's finals. What's more interesting is the way the NBA sorta kinda stands athwart the supercity-cization of the United States, by way of its strict rules for how much teams can spend and what Perry calls its 'socialist-y system' for paying players. It is not just not bad, Perry argues, but actively great that littler cities are able to compete. As coastal megalopolises hoover up whole industries and their workers, we all ought to have it in us to cheer on these finals. 'Courage I know we have in abundance … but [gun]powder — where shall we get a sufficient supply?' Abigail Adams, I was not familiar with your game! John Adams was, though. The future president once told his wife and pen pal: 'I really think that your Letters are much better worth preserving than mine.' The powder letter is pretty much exactly 250 years old, exchanged in the lead-up to the Revolutionary War, and the resolve it displays is remarkable, writes historian Joseph Ellis, considering the overwhelming uncertainty still swirling at that point. Britain was the world's hegemon, Ellis writes, yet the Adamses 'were like poker players who were all-in before knowing what cards they had been dealt.' Even more remarkable is the couple's prescience that their correspondence would be important some day, as John noted. Ellis writes: 'They were not just writing letters to each other; they were writing to posterity — which is to say, us.' So read up on what Ellis excerpts. Then, in our own era of uncertainty, maybe start writing, too. It's a goodbye. It's a haiku. It's … The Bye-Ku. NBA reckons With remotest finals sites This side of Oort cloud *** Have your own newsy haiku? Email it to me, along with any questions/comments/ambiguities. See you tomorrow!
Yahoo
4 hours ago
- Yahoo
Zest launches early dementia screening test
Zest has unveiled a new app-based cognitive test designed to screen for the early signs of dementia, as efforts ramp up in healthcare to protect against age-related neurological decline. Developed alongside a team at the University of Cambridge University's Memory Lab, the London-headquartered biotech's Precision Memory Assessment (PREMAZ) test is intended to detect subtle cognitive changes that may occur decades before the symptoms of dementia arise. PREMAZ works by focusing on testing in the areas of memory function most affected in early dementia: episodic- and recognition-related memory, the brain's processing speed, and executive function in relation to decision-making and working memory. By enabling earlier detection and empowering people to make preventative changes sooner, this technology could dramatically reduce the number of Alzheimer's cases and change the future of brain health, according to Zest. 'By moving this technology from the lab into people's hands, we're creating new opportunities for earlier detection, better interventions, and ultimately better outcomes,' explained Professor Jon Simons, Cambridge Memory Lab's lead and scientific director on the project with Zest. 'The sensitivity of our memory precision task means we can detect subtle memory changes at an early stage when they can still be remedied by cognitive and lifestyle interventions that may protect against further age-related decline.' Various companies are on the road towards developing early dementia detection tools, with each taking slightly different approaches towards the early detection of the neurodegenerative condition. Since gaining clearance from the US Food and Drug Administration (FDA) in January 2025, Oxford Brain Diagnostics (OBD) is gearing up to launch a software tool designed to evaluate the early signs of dementia by analysing MRI scans. Meanwhile, a research team led by the University of Edinburgh is using artificial intelligence (AI) to develop a software tool for use by optometrists to detect dementia risk from a routine eye test. Work is also underway in determining what factors may increase or reduce an individual's risk of developing dementia in later life. A study recently published in the Journal of Neurology Neurosurgery & Psychiatry found that people with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood had a lower risk of developing dementia. Further research suggests that those who experience hearing loss yet forego cochlear implants or hearing aids, may be at greater risk of developing dementia. "Zest launches early dementia screening test" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
